| Unadjusted HR (95% CI) | Adjusted HR (95% CI) |
---|---|---|
Age, years | 1.03 (0.99–1.06) |  |
Male sex | 1.00 (0.62–1.62) |  |
Vancomycin resistance | 1.38 (0.53–3.59) | 0.75 (0.24–2.36) |
SAPS II at the onset of BSI (per 1 point) | 1.12 (1.08–1.17) | 1.13 (1.08–1.18) |
Underlying hematologic diseases | Â | Â |
  AML | 1.00 |  |
  ALL | 0.78 (0.27–2.24) |  |
  Others | 2.29 (0.73–7.19) |  |
Treatment for underlying diseases | Â | Â |
  Chemotherapy | 1.00 |  |
  SCT | 1.33 (0.72–2.47) |  |
Length of hospitalization, day | 1.05 (1.02–1.09) | 1.00 (0.98–1.02) |
Duration of neutropenia before BSI, day | 1.00 (0.98–1.02) |  |
Severity of neutropenia | Â | Â |
  ANC (<500/mm3) | 1.00 |  |
  ANC (<100/mm3) | 0.43 (0.10–1.86) |  |
Delayed administration of adequate antibiotics (> 48 hours) | 0.78 (0.30–2.04) |  |